| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |